231 related articles for article (PubMed ID: 9893018)
1. Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity.
Li Y; Chen H; Tan J; Wang X; Liang H; Sun X
Eur J Clin Invest; 1998 Dec; 28(12):1050-4. PubMed ID: 9893018
[TBL] [Abstract][Full Text] [Related]
2. Blood coagulation and fibrinolysis in patients with hyperthyroidism.
Erem C; Ersoz HO; Karti SS; Ukinç K; Hacihasanoglu A; Değer O; Telatar M
J Endocrinol Invest; 2002 Apr; 25(4):345-50. PubMed ID: 12030606
[TBL] [Abstract][Full Text] [Related]
3. Study of endothelial t-PA and vWf in normal subjects and in von Willebrand's disease.
Wieczorek I; Ludlam CA; MacGregor IR
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):329-34. PubMed ID: 8075304
[TBL] [Abstract][Full Text] [Related]
4. Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.
Lau CS; McLaren M; Hanslip J; Kerr M; Belch JJ
Ann Rheum Dis; 1993 Sep; 52(9):643-9. PubMed ID: 8239758
[TBL] [Abstract][Full Text] [Related]
5. The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies.
van de Kar NC; van Hinsbergh VW; Brommer EJ; Monnens LA
Pediatr Res; 1994 Aug; 36(2):257-64. PubMed ID: 7970942
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.
Leurs PB; Stolk RP; Hamulyak K; Van Oerle R; Grobbee DE; Wolffenbuttel BH
Diabetes Care; 2002 Aug; 25(8):1340-5. PubMed ID: 12145232
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man.
Labinjoh C; Newby DE; Dawson P; Johnston NR; Ludlam CA; Boon NA; Webb DJ
Cardiovasc Res; 2000 Sep; 47(4):707-14. PubMed ID: 10974219
[TBL] [Abstract][Full Text] [Related]
8. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
9. In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins.
Bombeli T; Jutzi M; De Conno E; Seifert B; Fehr J
Blood Coagul Fibrinolysis; 2002 Oct; 13(7):577-81. PubMed ID: 12439142
[TBL] [Abstract][Full Text] [Related]
10. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
[TBL] [Abstract][Full Text] [Related]
11. Calcium regulation of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells.
Yamamoto C; Kaji T; Sakamoto M; Kozuka H; Koizumi F
Thromb Res; 1994 Apr; 74(2):163-8. PubMed ID: 8029817
[TBL] [Abstract][Full Text] [Related]
12. [Change of vWF, PAl-1 and t-PA in rats with hyperlipemia and its significance].
Jiang HH; Liu Y; Lin GQ; Li YQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):415-20. PubMed ID: 18544845
[TBL] [Abstract][Full Text] [Related]
13. In-vitro effect of oncostatin M on the release by endothelial cells of von Willebrand factor, tissue-type plasminogen activator and plasminogen activator inhibitor-1.
Pourtau J; Soria C; Paysant J; Vannier JP; Vasse M
Blood Coagul Fibrinolysis; 1998 Oct; 9(7):609-15. PubMed ID: 9863709
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-derived haemostatic factors and the antiphospholipid syndrome.
Mackworth-Young CG; Andreotti F; Harmer I; Loizou S; Pottinger BE; Pearson JD; Davies GJ; Maseri A; Walport MJ
Br J Rheumatol; 1995 Mar; 34(3):201-6. PubMed ID: 7728392
[TBL] [Abstract][Full Text] [Related]
15. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
16. Acute endothelial tissue plasminogen activator release in pregnancy.
Robb AO; Mills NL; Din JN; Cameron S; Ludlam CA; Newby DE; Denison FC
J Thromb Haemost; 2009 Jan; 7(1):138-42. PubMed ID: 18983502
[TBL] [Abstract][Full Text] [Related]
17. Von Willebrand factor and fibrinolytic parameters during the desmopressin test in patients with Cushing's disease.
Pecori Giraldi F; Ambrogio AG; Fatti LM; Rubini V; Cozzi G; Scacchi M; Federici AB; Cavagnini F
Br J Clin Pharmacol; 2011 Jan; 71(1):132-6. PubMed ID: 21143510
[TBL] [Abstract][Full Text] [Related]
18. The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning.
van Kesteren PJ; Kooistra T; Lansink M; van Kamp GJ; Asscheman H; Gooren LJ; Emeis JJ; Vischer UM; Stehouwer CD
Thromb Haemost; 1998 May; 79(5):1029-33. PubMed ID: 9609242
[TBL] [Abstract][Full Text] [Related]
19. Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis.
Takagi M; Wada H; Mukai K; Kihira H; Yano S; Minamikawa K; Wakita Y; Nakase T; Nagaya S; Deguchi K
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):713-7. PubMed ID: 7865676
[TBL] [Abstract][Full Text] [Related]
20. Response of fibrinolytic proteins and endothelin 1 to venous occlusion in patients on chronic hemodialysis.
Tomura S; Ando R; Chida Y; Ida T; Hirata Y; Marumo F; Tsuchiya S
Nephron; 1997; 77(4):394-8. PubMed ID: 9434059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
